KRAS G13D peptide, 25 mer

Modify Date: 2024-01-17 17:39:46

KRAS G13D peptide, 25 mer structure	Common Name	KRAS G13D peptide, 25 mer
	CAS Number	145019-94-9	Molecular Weight	2634.10
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₁₈H₂₀₁N₂₉O₃₆S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of KRAS G13D peptide, 25 mer

KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1].

Name	KRAS G13D peptide, 25 mer

Description	KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vitro	KRAS G13D peptide, 25 mer is encoded by immunomodulatory therapeutic mRNA that can be used to prepare KRAS vaccine[1].
References	[1]. Huang EYC, et, al. Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides. WO2018144775A1.

Molecular Formula	C₁₁₈H₂₀₁N₂₉O₃₆S
Molecular Weight	2634.10